Dossenheim, Germany

Harald Bluhm


Average Co-Inventor Count = 13.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Dossenheim, DE (2010)
  • Arnsberg-Neheim, DE (2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
3 patents (USPTO):

Title: The Innovations of Inventor Harald Bluhm

Introduction: Harald Bluhm is a distinguished inventor based in Dossenheim, Germany, recognized for his significant contributions to the field of pharmaceuticals. With a portfolio of three patents, he has made remarkable strides in the development of innovative compounds aimed at fighting various medical conditions.

Latest Patents: Bluhm's latest patents focus on heterobicyclic metalloprotease inhibitors. His inventions revolve around amide-containing heterobicyclic compounds. These compounds are designed to offer increased potency against known MMP-13 and MMP-3 inhibitors, showcasing a new class of pharmaceutical agents. His work provides valuable insights into the formulations that may enhance therapeutic outcomes for patients suffering from conditions related to these metalloproteases.

Career Highlights: Throughout his career, Harald Bluhm has made a name for himself by working with prominent companies such as Amgen Inc. and Atlantos Pharmaceuticals Holding, Inc. His tenure at these organizations underscores his commitment to advancing pharmaceutical research and innovation, where he has contributed to the development of potent therapeutic agents.

Collaborations: In his professional journey, Bluhm has collaborated with several notable individuals, including Christian Gege and Brian M Gallagher, Jr. These partnerships have played a crucial role in fostering innovation and driving the progress of his research projects.

Conclusion: As an inventor, Harald Bluhm continues to push the boundaries of pharmaceutical science with his innovative approaches to developing new compounds. His patents not only reflect his expertise but also his dedication to improving patient care through targeted therapies. The impact of his work is likely to resonate within the scientific community and beyond, paving the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…